T1	intervention 0 10	Raloxifene
T2	condition 20 50	Early Periprosthetic Bone Loss
T3	eligibility 55 115	Postmenopausal Women after Uncemented Total Hip Arthroplasty
T5	total-participants 357 360	240
T6	age 377 400	between 55 and 80 years
T7	intervention-participants 527 530	120
T8	control 535 542	placebo
T9	control-participants 567 570	120
T11	total-participants 1228 1231	240
T14	outcome 1590 1633	1, 4, 6, and 7 at 12 months postoperatively
T15	outcome 1700 1746	1, 2, 4, 6, and 7 at 24 months postoperatively
T16	outcome 1807 1817	QoL scores
T17	outcome 1961 1971	WOMAC pain
T18	outcome 1986 2000	WOMAC function
T19	outcome 2018 2036	women's QoL scores
T4	outcome 1453 1479	BMD of Gruen zones 4 and 7
